Skip to content

Effect of Butyrogenic Fibers in IBS Patients

Effect of an Enriched Butyrogenic Fibres Diet on Rectal Sensitivity in Healthy Control and IBS Patients.

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00314886
Enrollment
15
Registered
2006-04-17
Start date
2005-01-31
Completion date
2005-07-31
Last updated
2011-01-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Irritable Bowel Syndrome

Keywords

Diet, Fiber, Irritable Bowel Syndrome, Colonic Flora

Brief summary

Despite there being no clearcut advantages, one of the most common recommendations in IBS management is to increase the amount of dietary fibres. In some IBS patients fibres have a deleterious effect on pain and bloating. It has been shown that butyrate can increase colonic sensitivity in rats. Our purpose is to study whether butyrogenic fibres can modify rectal sensitivity and symptoms in IBS and healthy control through a modification of colonic flora.

Detailed description

Despite there being no clearcut advantages, one of the most common recommendations in IBS management is to increase the amount of dietary fibres. In some IBS patients fibres have a deleterious effect on pain and bloating. It has been shown that butyrate can increase colonic sensitivity in rats. Our purpose is to study whether butyrogenic fibres can modify rectal sensitivity and symptoms in IBS and healthy control through a modification of colonic flora.

Interventions

DRUGDiet

Sponsors

Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement
CollaboratorOTHER
EA 3848 UdA
CollaboratorUNKNOWN
ERT: Clinical Trial Technology Solutions
CollaboratorOTHER
University Hospital, Clermont-Ferrand
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* Female aged 18-60 years * Normal volunteers and patients with IBS assessed by Rome II criteria * Effective contraception * Affiliated to National Health Service * Having received oral and written information about the study * Having provided her written informed consent

Exclusion criteria

* Significant clinical or biological abnormality * Organic gastrointestinal disease * Subjects having lower than 15g/day or higher than 20g/day fibres intake * Antibiotic treatment during the month preceding the pre inclusion day * Antispasmodics, antidiarrheics, laxatives, and prokinetics during the week preceding the pre inclusion day and during all the study period. * Digestive surgery tract except appendectomy and cholecystectomy * Alcohol abuse * Drug addiction * Major psychiatric disorder

Design outcomes

Primary

MeasureTime frame
Discomfort threshold to rectal distension

Secondary

MeasureTime frame
Intestinal discomfort (questionnaire)
Quality of life (questionnaire)
Rectal sensitivity : first sensation and threshold for first sensation of the need to defecate.
Functional composition of colonic flora
Fermentation profile of ingested fibre
Taxonomic composition of colonic flora

Countries

France

Contacts

Primary ContactMichel Dapoigny, Pr
(33) 04 73 75 05 23

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026